Curexo Inc (060280) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.016x

Based on the latest financial reports, Curexo Inc (060280) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.49 Billion ≈ $-1.01 Million USD) by net assets (₩94.30 Billion ≈ $63.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Curexo Inc balance sheet independence to measure how much of total assets are equity-financed.

Curexo Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Curexo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Curexo Inc (060280) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Curexo Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Curexo Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Singer Thailand Public Company Limited BK:SINGER-R	0.006x
S-Oil Corp Pref KO:010955	0.103x
Duos Technologies Group Inc NASDAQ:DUOT	-0.064x
SC II Acquisition Corp. Class A ordinary share NASDAQ:SCII	14.005x
Pt Pakuan Tbk JK:UANG	-0.148x
JADESTONE ENERGY LS -001 F:8KW	N/A
SAMG Entertainment Co. Ltd. KQ:419530	-0.006x
Sinmag Equipment TWO:1580	0.085x

Annual Cash Flow Conversion Efficiency for Curexo Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Curexo Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 060280 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩93.38 Billion ≈ $63.28 Million	₩3.85 Billion ≈ $2.61 Million	0.041x	-18.50%
2023-12-31	₩100.43 Billion ≈ $68.06 Million	₩5.08 Billion ≈ $3.44 Million	0.051x	+131.58%
2022-12-31	₩81.68 Billion ≈ $55.35 Million	₩-13.08 Billion ≈ $-8.87 Million	-0.160x	+21.40%
2021-12-31	₩42.90 Billion ≈ $29.07 Million	₩-8.74 Billion ≈ $-5.92 Million	-0.204x	-496.60%
2020-12-31	₩44.79 Billion ≈ $30.36 Million	₩-1.53 Billion ≈ $-1.04 Million	-0.034x	+70.40%
2019-12-31	₩43.98 Billion ≈ $29.80 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.115x	+46.85%
2018-12-31	₩70.03 Billion ≈ $47.46 Million	₩-15.20 Billion ≈ $-10.30 Million	-0.217x	-911.18%
2017-12-31	₩70.69 Billion ≈ $47.91 Million	₩-1.52 Billion ≈ $-1.03 Million	-0.021x	+97.33%
2016-12-31	₩73.08 Billion ≈ $49.53 Million	₩-58.79 Billion ≈ $-39.84 Million	-0.804x	-36.21%
2015-12-31	₩33.51 Billion ≈ $22.71 Million	₩-19.79 Billion ≈ $-13.41 Million	-0.591x	+58.96%
2014-12-31	₩13.94 Billion ≈ $9.45 Million	₩-20.06 Billion ≈ $-13.60 Million	-1.439x	-246.31%
2013-12-31	₩35.09 Billion ≈ $23.78 Million	₩-14.58 Billion ≈ $-9.88 Million	-0.416x	-4.98%
2012-12-31	₩49.48 Billion ≈ $33.53 Million	₩-19.59 Billion ≈ $-13.27 Million	-0.396x	--

About Curexo Inc

KQ:060280 Korea Food & Drug Retailing

Market Cap

$176.55 Million

₩260.52 Billion KRW

Market Cap Rank

#17001 Global

#629 in Korea

Share Price

₩7810.00

Change (1 day)

+3.44%

52-Week Range

₩7550.00 - ₩20350.00

All Time High

₩24400.00